Moreover, FOXC1 presented a negative expression pattern with miR-137 in GECs, which promoted ZO-1 and occludin expression, led to an increase in BTB permeability, and promoted CXCR7 expression that activated glioma angiogenesis. The gene discussed is FOXC1; the disease is central nervous system cancer.